V015-2393 Screening compound: [2-(4-methylpiperazino)-4-(1-pyrrolidinyl)-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl](phenyl)methanone

V015-2393 Screening compound: [2-(4-methylpiperazino)-4-(1-pyrrolidinyl)-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl](phenyl)methanone
V015-2393 Screening compound: [2-(4-methylpiperazino)-4-(1-pyrrolidinyl)-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl](phenyl)methanone alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-2393
[2-(4-methylpiperazino)-4-(1-pyrrolidinyl)-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl](phenyl)methanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-2393

Molecular Formula

C23H30N6O (C23 H30 N6 O)

Compound Name

[2-(4-methylpiperazino)-4-(1-pyrrolidinyl)-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl](phenyl)methanone

IUPAC name

1-[6-benzoyl-4-(pyrrolidin-1-yl)-5H6H7H8H-pyrido[43-d]pyrimidin-2-yl]-4-methylpiperazine

SMILES

CN(CC1)CCN1c1nc(N2CCCC2)c(CN(CC2)C(c3ccccc3)=O)c2n1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

406.53

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.691

Distribution Coefficient, logD

2.119

Water Solubility, LogSw

-2.73

Polar Surface Area

46.228

Acid Dissociation Constant (pKa)

20.03

Base Dissociation Constant (pKb)

7.84

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.17

V015-2393 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V015-2393 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-2393?
Check Price and Availability of V015-2393, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-2393 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-2393
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-2393
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-2393 available by request